Reduced Use Of Erythropoiesis-Stimulating Agents and Intravenous Iron with Ferric Citrate: A Medicare Bundle Cost-Offset Model


Mutell R, Rubin JL, Bond TC, Mayne T. Reduced use Of erythropoiesis-stimulating agents and intravenous iron with ferric citrate: A medicare bundle cost-offset model. International Society for Pharmacoeconomics and Outcomes Research. Washington, DC, Jun 2-6, 2012.